You are here: Home » News-IANS » Lifestyle-Fashion
Business Standard

Testosterone replacement therapy may slow progression of COPD

IANS  |  New York 

replacement therapy may slow the progression of (COPD), a new study has found.

is a group of that causes airflow blockage and breathing-related problems including and

The findings, published in the journal Chronic Respiratory Disease, suggested that middle-aged replacement therapy users had a 4.2 per cent greater decrease in respiratory hospitalisations compared with non-users.

According to the World Organization (WHO), is predicted to be the third leading cause of and death internationally by 2030.

"We found that users had a greater decrease in respiratory hospitalisations compared with non-users," said Jacques Baillargeon, at the in the US.

Low testosterone is common in men with and may worsen their condition. Men with COPD have and often take steroid-based medications for an extended time, both of which increase their risk of low testosterone, the team said.

For the study, the researchers examined data of 450 men aged between 40 and 63 with COPD who began between 2005 and 2014.

They also used the national database to study data from 253 men with COPD aged 66 and above who initiated between 2008 and 2013.

The researchers also found that older users had a 9.1 per cent greater decrease in respiratory hospitalisations compared with non-users.

The aim of the study was to find out whether testosterone replacement therapy reduced the risk of respiratory hospitalisations in middle-aged and older men with COPD, the team said.

"Previous studies have suggested that testosterone replacement therapy may have a positive effect on lung function in men with COPD. However, we are the first to conduct a large scale nationally study on this association," Baillargeon said.



(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Fri, September 14 2018. 16:00 IST